Michael Kalafatis Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

12/2018	Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer.
1/2018	Sensitization of recombinant human tumor necrosis factor-related apoptosis-inducing ligand-resistant malignant melanomas by quercetin.
1/2018	TRAIL-Induced Apoptosis in TRAIL-Resistant Breast Carcinoma Through Quercetin Cotreatment.
12/2017	Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment.
9/2017	The Case Back on the TRAIL: Death Receptors as Markers for rhTRAIL Sensitivity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Kalafatis Research Topics

Disease

5	Neoplasms (Cancer) 12/2018 - 09/2017
3	Breast Neoplasms (Breast Cancer) 12/2018 - 12/2017
2	Triple Negative Breast Neoplasms 12/2018 - 12/2017
1	Melanoma (Melanoma, Malignant) 01/2018
1	Thrombosis (Thrombus) 03/2005
1	Vascular System Injuries 03/2005
1	Activated Protein C Resistance (APC Resistance) 06/2002

Drug/Important Bio-Agent (IBA)

5	LigandsIBA 12/2018 - 09/2017
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2018 - 09/2017
2	QuercetinIBA 01/2018 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 01/2018
1	Ursolic AcidIBA 12/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Silybin (Lagosa)IBA 12/2017
1	Death Domain ReceptorsIBA 09/2017
1	Prothrombin (Factor II)IBA 03/2005
1	Thrombin FDA Link 03/2005
1	Thromboplastin (Tissue Factor)IBA 03/2005
1	Factor VaIBA 03/2005
1	EpitopesIBA 06/2002
1	Immunoglobulins (Immunoglobulin)IBA 06/2002
1	Factor V (Coagulation Factor V)IBA 06/2002

Therapy/Procedure

2	Therapeutics 12/2018 - 12/2017